Where this storyline stands
The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments found that the protocol was safe, with no serious adverse events or increases in suicidal thinking or behavior.
Complete chronological journey
Every chapter below is ordered by its exact event time, from the earliest connected report to the newest development.
- 01How it started01 — How it started
For veterans with severe PTSD, psilocybin-assisted therapy may help
What happened
The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments found that the protocol was safe, with no serious adverse events or increases in suicidal thinking or behavior. For veterans with severe PTSD, psilocybin-assisted therapy may help
Why it matters
The development may affect how technology is built, regulated or used. The practical impact depends on technical details, availability and independent evaluation.